Yahoo Search Búsqueda en la Web

Resultado de búsqueda

1. www.mdpi.com › 2311/7524/10-9 › 965Horticulturae | Free Full-Text | CRISPR/Cas in Grapevine Genome...

   www.mdpi.com › 2311/7524/10-9 › 965

   • En caché

   Hace 18 horas · Ren, Chong, Mohamed Salaheldin Mokhtar Mohamed, Nuremanguli Aini, Yangfu Kuang, and Zhenchang Liang. 2024. "CRISPR/Cas in Grapevine Genome Editing: The Best Is Yet to Come" Horticulturae 10, no. 9: 965

2. Videos

   • 1:39

     youtube.com

     CRISPR Explained

     24 jul 2018

     1.4M vistas

   • 14:27

     youtube.com

     CRISPR-Cas9 Genome Editing Technology

     29 oct 2021

     625.2K vistas

   • 1:18

     youtube.com

     How CRISPR Cas9 works (animation explained in 1 minute)

     20 nov 2020

     37.7K vistas

   Ver todo

3. tffpharma.com › press_releases › tff-pharmaceuticals-partners-with-emoryTFF Pharmaceuticals Partners with Emory University and BARDA to...

   tffpharma.com › press_releases › tff-pharmaceuticals-partners-with-emory

   • En caché

   Hace 7 horas · The FASTx program is designed to transform antiviral therapy by developing rapidly adaptable platforms to combat viral threats through the use of next generation technology such as clustered regular interspaced short palindromic repeat-associated proteins (CRISPR-Cas), which can be rapidly manufactured in response to emerging viral threats.

4. www.sigmaaldrich.com › BR › enCRISPR-Lenti Human HPRT1 Positive Control Transduction Particles

   www.sigmaaldrich.com › BR › en

   • En caché

   12 de sept. de 2024 · CRISPR-Lenti Human HPRT1 Positive Control Transduction Particles; find Sigma-Aldrich-CRISPR13V MSDS, related peer-reviewed papers, technical documents, similar products & more at Sigma-Aldrich

5. Imágenes

   • 
   • 
   • 
   • 

   Ver todo

6. menafn.com › 1108661578 › TFF-Pharmaceuticals-Partners-With-Emory-University-AndTFF Pharmaceuticals Partners With Emory University And BARDA To...

   menafn.com › 1108661578 › TFF-Pharmaceuticals-Partners-With-Emory-University-And

   • En caché

   Hace 18 horas · 9/11/2024 7:16:20 AM. Share on Facebook; Tweet on Twitter (MENAFN- GlobeNewsWire - Nasdaq) ... (CRISPR-Cas), which can be rapidly manufactured in response to emerging viral threats. ...

7. uk.marketscreener.com › quote › stockTFF Pharmaceuticals Partners with Emory University and BARDA to...

   uk.marketscreener.com › quote › stock

   • En caché

   Hace 18 horas · 138d8e489.KLoUAhfWJP1u2tQE3qIrH0JyWFhagv8jXwr-7CPypBw.S893SnKUQM07rrB06PhlJ3FEYDcM84Zqa16UrhOIk3gQ7SwwQOJijVasgQ

8. www.wallstreet-online.de › nachricht › 18477588-tff-pharmaceuticals-partners-withTFF Pharmaceuticals Partners with Emory University and BARDA to...

   www.wallstreet-online.de › nachricht › 18477588-tff-pharmaceuticals-partners-with

   • En caché

   Hace 18 horas · 11.09.2024 - Partnership funded by BARDA and other US government agencies TFF formulation may provide flexibility of delivery and improve storage and distribution conditions FORT WORTH, Texas ...

9. www.biomart.cn › 69899 › newsCRISPR基因编辑技术：激活Nrf2，为肾病治疗带来新希望 ...

   www.biomart.cn › 69899 › news

   • En caché

   Hace 18 horas · 这项研究证实， CRISPR/Cas9 技术在体外对小鼠 CD4+ T 细胞进行 Keap1 基因敲除，能够激活 Nrf2 依赖的抗氧化应答基因，为肾脏 IRI 提供保护。 一、 使用 CRISPR/Cas9 技术敲除 Keap1 增强 Nrf2 靶基因表达.